BRCA2 and ovarian cancer: In a study of 200 Polish families with three or more breast or ovarian cancers a BRCA1/2 mutation was identified in 64 %; the prevalence of BRCA1 mutations was 60 % and the prevalence of BRCA2 mutations was 4 % [32].